1 / 28

The Nuts and Bolts of Omega-3 Fatty Acids in Hypertriglyceridemia Treatment

The Nuts and Bolts of Omega-3 Fatty Acids in Hypertriglyceridemia Treatment. 2013 ACC/AHA Guidelines for Elevated TGs. ATP III Treatment Recommendations for Elevated TGs. Triglyceride Levels What Is Considered High?.

anthea
Download Presentation

The Nuts and Bolts of Omega-3 Fatty Acids in Hypertriglyceridemia Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Nuts and Bolts of Omega-3 Fatty Acids in Hypertriglyceridemia Treatment

  2. 2013 ACC/AHA Guidelines for Elevated TGs

  3. ATP III Treatment Recommendations for Elevated TGs

  4. Triglyceride LevelsWhat Is Considered High?

  5. Triglyceride Level Is A Significant CVD Risk Factor Recent Meta-Analysis of 29 Studies

  6. Prescription-only Omega-3s vs Dietary Supplement Omega-3s

  7. Bioavailability Based on Fatty Acid Constituents

  8. Omega-3 Ethyl Esters and Lipid Levels in Patients With Triglycerides > 500 mg/dL

  9. Statin + OM-3COMBOS Primary and Secondary Efficacy Results

  10. Icosapent Ethyl (Pure EPA)Median Placebo-Adjusted Change From Baseline for Efficacy End Points

  11. ANCHOR Icosapent Ethyl Change in Lipid End Points

  12. OM-3-FFA Change in Lipid End Points

  13. Select Omega-3 Outcomes Studies

  14. REDUCE-IT Study

  15. Recommendations When Triglycerides  500 mg/dL

  16. Effects of Nutrition Practices on TG Level Lowering

  17. Lipid Effects of Drug Classes in Dyslipidemia and Hypertriglyceridemia

  18. Safety of Omega-3 Fatty Acids

  19. Abbreviations

  20. Abbreviations (cont)

  21. Abbreviations (cont)

  22. References

  23. References (cont)

  24. References (cont)

  25. References (cont)

  26. References (cont)

More Related